In a trial, radiotherapy raised three-year survival rates to 81 per cent, compared with 73 per cent for standard care patients.
Chris Parker, lead researcher at London’s Royal Marsden Hospital, told The Times: “Until now, it was thought that there was no point in treating the prostate itself if the cancer had spread because it would be like shutting the stable door after the horse has bolted.
“However, this study proves the benefit of prostate radiotherapy.”
Cancer Research UK’s Charles Swanton said: “This is a monumental finding that could help thousands worldwide.”
The trial involved 2,000 men. Prostate cancer kills 11,500 in the UK a year.
- GOT a story? Ring The Sun on 0207 782 4104 or WHATSAPP on 07423720250 or email [email protected]
Source: Read Full Article